HomeAYTU • NASDAQ
add
Aytu Biopharma Inc
Previous close
$2.80
Day range
$2.71 - $2.87
Year range
$1.38 - $3.50
Market cap
15.31M USD
Avg Volume
18.10K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 22.93M | -12.73% |
Operating expense | 13.84M | -35.59% |
Net income | -220.00K | 96.71% |
Net profit margin | -0.96 | 96.23% |
Earnings per share | — | — |
EBITDA | 4.54M | 328.64% |
Effective tax rate | 136.18% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 19.53M | 0.14% |
Total assets | 131.25M | -7.20% |
Total liabilities | 98.40M | 2.90% |
Total equity | 32.85M | — |
Shares outstanding | 5.57M | — |
Price to book | 0.47 | — |
Return on assets | 4.47% | — |
Return on capital | 11.89% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -220.00K | 96.71% |
Cash from operations | -135.00K | 94.47% |
Cash from investing | -174.00K | -3,380.00% |
Cash from financing | -126.00K | 93.24% |
Net change in cash | -435.00K | 89.91% |
Free cash flow | 835.88K | 134.70% |
About
Founded
2002
Headquarters
Website
Employees
150